Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Hikma Pharma signs agreement with Civica Rx to produce 14 sterile injectable medications

      Hikma Pharma signs agreement with Civica Rx to produce 14 sterile injectable medications

      Medical Dialogues Bureau4 Aug 2019 9:10 AM IST
      Under the agreement, Hikma will produce 14 essential sterile injectable medications for Civica as a private label distributor, using Hikma's...
      Protest planned outside court during Purdue Pharma hearing

      Protest planned outside court during Purdue Pharma hearing

      Medical Dialogues Bureau4 Aug 2019 9:00 AM IST
      Purdue Pharma will argue in Suffolk Superior Court that Democratic state Attorney General Maura Healey's lawsuit distorts facts, makes oversimplified...
      Zydus Cadila wins USFDA nod for Minocycline Hydrochloride ER tablets to treat acne

      Zydus Cadila wins USFDA nod for Minocycline Hydrochloride ER tablets to treat acne

      Medical Dialogues Bureau3 Aug 2019 9:45 AM IST
      Minocycline hydrochloride extended-release tablets are indicated to treat only inflammatory lesions of non-modular moderate to severe acne vulgaris in...
      Pfizer, GSK completes transaction to form new consumer healthcare JV

      Pfizer, GSK completes transaction to form new consumer healthcare JV

      Medical Dialogues Bureau3 Aug 2019 9:40 AM IST
      The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and...
      Novartis, Gilead costly cancer therapies Yescarta, Kymriah losing patients to experimental treatments

      Novartis, Gilead costly cancer therapies Yescarta, Kymriah losing patients to experimental treatments

      Medical Dialogues Bureau3 Aug 2019 9:15 AM IST
      Both Gilead's Yescarta and Novartis's Kymriah - which are part of a class of therapies known in the medical field as "CAR-T" - were approved in 2017....
      Philippines weighs re-use of Sanofi controversial dengue vaccine Dengvaxia

      Philippines weighs re-use of Sanofi controversial dengue vaccine Dengvaxia

      Medical Dialogues Bureau3 Aug 2019 9:14 AM IST
      The Philippines stopped using Dengvaxia in late 2017 and ordered Sanofi to stop selling, distributing and marketing it after Sanofi warned the vaccine...
      Enforcement Directorate raids premises of ex-Ranbaxy/Fortis Promoters on allegations of money laundering

      Enforcement Directorate raids premises of ex-Ranbaxy/Fortis Promoters on allegations of money laundering

      Medical Dialogues Bureau2 Aug 2019 11:40 AM IST
      They said the raids were conducted at seven locations in Delhi including those connected to the Singh brothers, ex-CMD of Religare Enterprises Ltd...
      Biocon, Mylan launch biosimilar Ogivri for treatment of breast, stomach cancer in Australia

      Biocon, Mylan launch biosimilar Ogivri for treatment of breast, stomach cancer in Australia

      Medical Dialogues Bureau2 Aug 2019 9:45 AM IST
      Ogivri is the first trastuzumab biosimilar approved and launched in Australia and available on the Pharmaceutical Benefits Scheme (PBS), Biocon and...
      Strides Pharma independent director Sangita Reddy to step down

      Strides Pharma independent director Sangita Reddy to step down

      Medical Dialogues Bureau2 Aug 2019 9:30 AM IST
      In spite of Sangita Reddy's preoccupation as a successful entrepreneur, she contributed significantly to the company's growth particularly when it was...
      Pharma companies resist Trump plan to import drugs

      Pharma companies resist Trump plan to import drugs

      Medical Dialogues Bureau2 Aug 2019 9:00 AM IST
      The U.S. Department of Health and Human Services (HHS) said it and the Food and Drug Administration will propose a rule that will allow it to...
      Sun Pharma to ramp up global speciality business; eyes "low-to-mid teens" growth in revenues for FY20

      Sun Pharma to ramp up global speciality business; eyes "low-to-mid teens" growth in revenues for FY20

      Medical Dialogues Bureau1 Aug 2019 10:00 AM IST
      The company is targeting key ailments like psoriasis to gradually ramp up its global speciality business, Dilip Shanghvi said adding that Sun Pharma...
      Biocon CSR arm unveils integrated program for Non-Communicable Diseases screening

      Biocon CSR arm unveils integrated program for Non-Communicable Diseases screening

      Medical Dialogues Bureau1 Aug 2019 9:30 AM IST
      In her communique, Dr Kiran Mazumdar Shaw, Managing Trustee, Biocon Foundation said, “We appreciate the sincere efforts of our Pourakarmikas to...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok